dpp 4 inhibitor with glp 1 Mechanisms of dipeptidyl peptidase‐4 (DPP‐4) inhibitors, glucagon‐like Role of DPP-4 Inhibitors in

These compounds play a pivotal role in modulating the gut microbiome, which in turn influences intestinal health and liver detoxification through complex molecular mechanisms and signaling pathways (121, 123)

Both are early enough in development that the published endpoints are surrogates body weight, HbA1c, liver fat measured over trial-length follow-up

GhoshNDasABiswasNGnyawaliSSinghKGorainMet al

According to the lawsuit, the companies failed to adequately warn healthcare providers and patients about the potential risks associated with these drugs, despite evidence and reports of gastrointestinal issues dating back to 2010

To qualify for weight-management treatment, patients typically need a BMI of 27 or higher, with most programs also considering weight-related health conditions such as high blood pressure, type 2 diabetes, or high cholesterol